Product Information
DROSP-EE-LEVOMEF 3-0.03-0.451 is a generic product labeled by Sandoz Inc., priced at $3.1818 per EA under NDC 00781410315. Its NADAC has been published 167 times since Sep 23, 2020.
DROSP-EE-LEVOMEF 3-0.03-0.451
Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calciumManufacturer
Sandoz Inc.NDC
00781410315
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA022574On Market Since
8/1/2015
Price Statistics
The NADAC for DROSP-EE-LEVOMEF 3-0.03-0.451 has been published 167 times since Sep 23, 2020, and over the history we have for it it has declined 30.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1818 per EA |
|---|---|
| All-time high | $4.5983 (Sep 15, 2021) |
| All-time low | $2.9572 (Aug 21, 2024) |
| 52-week high | $3.5667 |
| 52-week low | $2.9915 |
| Median price | $3.3593 |
| Average price | $3.6843 |
| Largest weekly change | -22.1% (Apr 17, 2024) |
| Weeks tracked | 167 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROSP-EE-LEVOMEF 3-0.03-0.451?
The current National Average Drug Acquisition Cost (NADAC) for DROSP-EE-LEVOMEF 3-0.03-0.451, manufactured by Sandoz Inc., is $3.1818 per EA (NDC 00781410315), effective Jun 24, 2026.
How has the price of DROSP-EE-LEVOMEF 3-0.03-0.451 changed over time?
Over the history we have for it, the NADAC for DROSP-EE-LEVOMEF 3-0.03-0.451 has declined 30.8%. It has been tracked across 167 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for DROSP-EE-LEVOMEF 3-0.03-0.451?
Since Sep 23, 2020, the NADAC for DROSP-EE-LEVOMEF 3-0.03-0.451 has ranged from a low of $2.9572 (Aug 21, 2024) to a high of $4.5983 (Sep 15, 2021), with a median of $3.3593 per EA.
Are there cheaper alternatives to DROSP-EE-LEVOMEF 3-0.03-0.451?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DROSP-EE-LEVOMEF 3-0.02-0.451, is $1.5617 per EA — about 51% below DROSP-EE-LEVOMEF 3-0.03-0.451.
Who manufactures DROSP-EE-LEVOMEF 3-0.03-0.451?
DROSP-EE-LEVOMEF 3-0.03-0.451 (NDC 00781410315) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification